Should a blood culture positive for Proteus mirabilis be treated?

Yes, blood culture positive for Proteus mirabilis should be treated with antibiotics.

Proteus mirabilis bacteremia represents true bloodstream infection requiring antimicrobial therapy, not a contaminant. Unlike common skin flora that frequently contaminate blood cultures, Proteus mirabilis is a pathogenic gram-negative organism that causes genuine invasive infections when isolated from blood cultures 1.

Why Treatment is Mandatory

Proteus mirabilis bacteremia carries significant morbidity and mortality risk:

• High mortality rates, particularly with ESBL-producing strains where attributable mortality is significantly elevated (P = 0.04) 2
• Risk of metastatic complications including infective endocarditis (though rare, it is well-documented) 3, 4 and embolic stroke 3
• Treatment failure occurs in approximately 45% of cases with ESBL-positive strains if inappropriate antibiotics are used 2

Clinical Approach

Immediate actions upon positive blood culture:

1. Initiate empiric broad-spectrum antibiotics while awaiting susceptibility results

2. Identify the source - most commonly:

   • Urinary tract (most frequent) 4
   • Biliary tract
   • Intra-abdominal infections
   • Consider endocarditis if no obvious source found, especially with persistent bacteremia 3, 5, 4

3. Obtain susceptibility testing - critical because:

   • ESBL-producing strains require carbapenem therapy 2
   • Non-ESBL strains respond to extended-spectrum cephalosporins 2
   • Carbapenems are associated with complete response regardless of ESBL status 2

Antibiotic Selection

For ESBL-negative strains:

• Ceftriaxone or other extended-spectrum cephalosporins are effective 2, 3, 5
• Treatment duration: typically 2 weeks for uncomplicated bacteremia

For ESBL-positive strains:

• Carbapenems are the treatment of choice (meropenem, imipenem, or ertapenem) 2
• Avoid cephalosporins and monobactams - associated with therapeutic failure 2

For endocarditis (if diagnosed):

• 6 weeks of IV therapy required 3, 5, 4
• Ceftriaxone has been successfully used in multiple case reports 3, 5

Critical Pitfalls to Avoid

⚠️ Do not dismiss as contaminant - Proteus mirabilis in blood cultures represents true infection, not contamination. The contamination guidelines 6 focus on skin flora (coagulase-negative staphylococci, Bacillus, Corynebacterium), not enteric gram-negative rods.

⚠️ Do not use empiric cephalosporins alone without susceptibility data - ESBL prevalence varies by institution, and therapeutic failure with inappropriate antibiotics significantly increases mortality 2.

⚠️ Consider endocarditis evaluation if:

• No obvious source identified
• Persistent or recurrent bacteremia 5, 4
• Neurologic symptoms or embolic phenomena 3, 4
• Risk factors: prosthetic valves, IV drug use, prior endocarditis 3

⚠️ Risk factors for ESBL-producing strains include:

• Nursing home residence (P = 0.04) 2
• Bladder catheter use (P = 0.01) 2
• Consider empiric carbapenem in these patients

Source Control

Beyond antibiotics, identify and address the source:

• Remove urinary catheters if present
• Drain abscesses
• Address biliary obstruction
• Evaluate for endocarditis with echocardiography if indicated 4

The evidence consistently demonstrates that untreated Proteus mirabilis bacteremia leads to poor outcomes, while appropriate antibiotic therapy based on susceptibility testing results in clinical cure 2, 3, 5.